GW&K Investment Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $72K | Buy |
161
+18
| +13% | +$8.05K | ﹤0.01% | 462 |
|
|
2025
Q1 | $69K | Buy |
143
+11
| +8% | +$5.31K | ﹤0.01% | 440 |
|
|
2024
Q4 | $53K | Sell |
132
-1
| -0.8% | -$402 | ﹤0.01% | 466 |
|
|
2024
Q3 | $62K | Buy |
133
+32
| +32% | +$14.9K | ﹤0.01% | 442 |
|
|
2024
Q2 | $47K | Buy |
101
+18
| +22% | +$8.38K | ﹤0.01% | 452 |
|
|
2024
Q1 | $35K | Sell |
83
-13
| -14% | -$5.48K | ﹤0.01% | 462 |
|
|
2023
Q4 | $39K | Buy |
96
+3
| +3% | +$1.22K | ﹤0.01% | 433 |
|
|
2023
Q3 | $32K | Buy |
93
+4
| +4% | +$1.38K | ﹤0.01% | 434 |
|
|
2023
Q2 | $31K | Buy |
+89
| New | +$31K | ﹤0.01% | 427 |
|
|
2022
Q3 | – | Sell |
-30
| Closed | -$8K | – | 808 |
|
|
2022
Q2 | $8K | Buy |
30
+12
| +67% | +$3.2K | ﹤0.01% | 505 |
|
|
2022
Q1 | $5K | Buy |
+18
| New | +$5K | ﹤0.01% | 556 |
|